US Federal Trade Commission Challenges Surmodics-Biocoat Merger Over Antitrust Concerns

 
• By Elizabeth Orr
  
Sign Above Federal Trade Commission Entrance, Washington, DC
(DCStockPhotography/Shutterstock)

More from Medtech Insight

More from Geography